(a) Chemical substance and significant new uses subject to reporting.
(1) The chemical substance identified as a thiadiazole derivative (PMN P-94-1631) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Industrial, commercial, and consumer activities. Requirements as specified in § 721.80 (a), (c), (f), (v)(1), (w)(1), and (x)(1).
(ii) Release to water. Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where n = 90).
(b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.
(1) Recordkeeping. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.
(2) Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.
[60 FR 45085, Aug. 30, 1995]